BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma D, Chen X, Shen X, Sheng LQ, Liu XH. Binding patterns and structure–activity relationship of CDK8 inhibitors. Bioorganic Chemistry 2020;96:103624. [DOI: 10.1016/j.bioorg.2020.103624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Miller KJ, Asim M. Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer. Cells 2022;11:952. [DOI: 10.3390/cells11060952] [Reference Citation Analysis]
2 Yu M, Long Y, Yang Y, Li M, Teo T, Noll B, Philip S, Wang S. Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation. Eur J Med Chem 2021;218:113391. [PMID: 33823391 DOI: 10.1016/j.ejmech.2021.113391] [Reference Citation Analysis]
3 Yan Y, Xing C, Xiao Y, Shen X, Zhang Z, He C, Shi JB, Liu M, Liu X. Discovery and Anti-Inflammatory Activity Evaluation of a Novel CDK8 Inhibitor through Upregulation of IL-10 for the Treatment of Inflammatory Bowel Disease In Vivo. J Med Chem 2022. [PMID: 35536548 DOI: 10.1021/acs.jmedchem.2c00356] [Reference Citation Analysis]
4 Siapkaras PD, Johansson Solum E. Ergosterol Analogs as Inhibitors of Cyclin Dependent Kinase 8. Steroids 2022. [DOI: 10.1016/j.steroids.2022.108965] [Reference Citation Analysis]